Your browser doesn't support javascript.
loading
Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib.
Mian, Michael; Pescosta, Norbert; Badiali, Stefania; Cappelletto, Paola Cristina; Marcheselli, Luigi; Luminari, Stefano; Patriarca, Francesca; Zambello, Renato; Pascarella, Anna; Tagariello, Giuseppe; Marabese, Alessandra; Mondello, Patrizia; Billio, Atto; Cortelazzo, Sergio.
Afiliação
  • Mian M; Department of Haematology & CBMT, Hospital of Bolzano, Bolzano, Italy.
  • Pescosta N; Internal Medicine V, Haematology & Oncology, Medical University of Innsbruck, Innsbruck, Austria.
  • Badiali S; Department of Haematology & CBMT, Hospital of Bolzano, Bolzano, Italy.
  • Cappelletto PC; Fondazione Italiana LInfomi, Modena and Alessandria, Italy.
  • Marcheselli L; Hospital Pharmacy, Hospital of Bolzano, Bolzano, Italy.
  • Luminari S; Fondazione Italiana LInfomi, Modena and Alessandria, Italy.
  • Patriarca F; Haematology, Santa Maria Nuova Hospital, IRCCS, Reggio Emilia, Italy.
  • Zambello R; ClinicaEmatologica e Unita' di TerapieCellulari "Carlo Melzi", Azienda Ospedaliera-Universitaria, Udine, Italy.
  • Pascarella A; Padua University School of Medicine, Padova, Italy.
  • Tagariello G; U.O. Ematologia, Ospedaledell'Angelo, Venezia-Mestre, Italy.
  • Marabese A; Transfusion Service, Haemophilia Centre and Haematology, Laboratory Analysis, Castelfranco Veneto Hospital, Castelfranco Veneto, Italy.
  • Mondello P; Department of Haematology & CBMT, Hospital of Bolzano, Bolzano, Italy.
  • Billio A; Department of Human Pathology, University of Messina, Messina, Italy.
  • Cortelazzo S; Department of Biological and Environmental Sciences, University of Messina, Messina, Italy.
Br J Haematol ; 185(5): 944-947, 2019 06.
Article em En | MEDLINE | ID: mdl-30478966

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Talidomida / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Bortezomib / Cloridrato de Bendamustina / Mieloma Múltiplo Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Talidomida / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Bortezomib / Cloridrato de Bendamustina / Mieloma Múltiplo Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article